Citadel Advisors
UNCY icon

Citadel Advisors’s Unicycive Therapeutics UNCY Stock Holding History

Citadel Advisors’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
236,841
-21,460
-8% -$141K ﹤0.01% 6635
2025
Q4 		$1.49M Buy
258,301
+216,627
+520% +$1.16M ﹤0.01% 6525
2025
Q3 		$182K Buy
+41,674
New +$182K ﹤0.01% 11357
2024
Q2 		– Sell
-6,940
Closed -$95.8K – 15551
2024
Q1 		$95.8K Buy
6,940
+3,398
+96% +$41.2K ﹤0.01% 11425
2023
Q4 		$30.7K Buy
+3,542
New +$23.2K ﹤0.01% 12249
2022
Q3 		– Sell
-1,521
Closed -$13K – 13878
2022
Q2 		$13K Sell
1,521
-2,199
-59% -$21K ﹤0.01% 12526
2022
Q1 		$48K Buy
+3,720
New +$54.5K ﹤0.01% 12819

Other funds holding UNCY

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $1.94B AUM 444.09% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $1.89B AUM 112.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return